Ask the Doctor

Dr. Kazuo Minematsu, the Emeritus Director General of the National Cerebral and Cardiovascular Center discusses blood clots.

Dr. Kazuo Minematsu who has been involved in the treatment and research of stroke for approximately 40 years discusses clot dissolution with tPA, and intravascular treatment.

Dr. Hiroaki Kumano, who specializes in psychosomatic medicine and is an expert in stress management discusses stress-related illness.

Dr. Kazuo Minematsu discusses the signs of a stroke.

Dr. Hiroaki Kumano a specialist in psychosomatic medicine discusses stress management.

Dr. Kazuo Minematsu, the Emeritus Director General of the National Cerebral and Cardiovascular Center discusses rehabilitation from a stroke.

Dr. Hiroaki Kumano, who specializes in psychosomatic medicine discusses behavior modification to help stress.

Dr. Hiroaki Kumano discusses meditation.

Dr. Yoshiharu Kawaguchi discusses types of lower back pain.

Focusing on lumbar disc herniation and spondylolisthesis.

Sudden, extreme pain in the lower back, acute low back pain.

Pain in the lower back that persists for more than 3 months; the BS-POP test.

Angina, a constricting pain around the chest, caused by a lack of oxygen and nutrients carried to the heart.

Angina, due to constriction of the blood vessels and myocardial infarction caused by blockages in the coronary arteries, resulting in poor blood flow and necrosis of cells in the heart.

Atrial fibrillation is an irregular pulse that could result in an acute stroke.

When the heart can no longer function effectively as a pump; symptoms and preventative measures.

Type 2 diabetes, triggered by overeating and a lack of exercise.

Blood glucose control to avoid complications; discuss symptoms as well as treatments.

Serious cases of low blood glucose may trigger life-threatening strokes and heart attacks.

The right amount of energy and a well-balanced diet are central to diabetic treatment.

Chest X-rays; cytology; CT scans.

Smoking is the greatest cause of lung cancer.

urgery is an effective option from stage I to early stage III lung cancer; lobectomy; VATS.

Chemotherapy, including molecularly targeted drugs and VEGF inhibitors; immune checkpoint inhibitors.